Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

253 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
It is important research, but why is it necessary?
Woosley RL. Woosley RL. Clin Pharmacol Ther. 2013 Apr;93(4):297-9. doi: 10.1038/clpt.2013.15. Clin Pharmacol Ther. 2013. PMID: 23511783
They are from the government and they really are here to help you.
Woosley RL. Woosley RL. J Clin Pharmacol. 2008 Feb;48(2):142-3. doi: 10.1177/0091270007313559. J Clin Pharmacol. 2008. PMID: 18199889 No abstract available.
CredibleMeds.org: What does it offer?
Woosley RL, Black K, Heise CW, Romero K. Woosley RL, et al. Trends Cardiovasc Med. 2018 Feb;28(2):94-99. doi: 10.1016/j.tcm.2017.07.010. Epub 2017 Aug 1. Trends Cardiovasc Med. 2018. PMID: 28801207 Review.
One hundred years of drug regulation: where do we go from here?
Woosley RL. Woosley RL. Annu Rev Pharmacol Toxicol. 2013;53:255-73. doi: 10.1146/annurev-pharmtox-011112-140159. Epub 2012 Oct 16. Annu Rev Pharmacol Toxicol. 2013. PMID: 23072378 Review.
The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.
Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL. Romero K, et al. Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165. Clin Pharmacol Ther. 2009. PMID: 19763117
Drug development and the FDA's Critical Path Initiative.
Woosley RL, Cossman J. Woosley RL, et al. Clin Pharmacol Ther. 2007 Jan;81(1):129-33. doi: 10.1038/sj.clpt.6100014. Clin Pharmacol Ther. 2007. PMID: 17186012
253 results
Jump to page
Feedback